- Financial Activist Dasha Kennedy’s 15 Money Non-Negotiables for 2025 — What Are Yours?
- Bain Capital ups bid for Australia’s Insignia to $1.8 billion, matching CC Capital
- Finance Minister Smotrich Collects PA’s Entire Billion-Dollar Debt | The Jewish Press – JewishPress.com | David Israel | 12 Tevet 5785 – Sunday, January 12, 2025
- Elon Musk wants to ‘delete’ many Americans’ financial lifeline
- Can Trump Fulfill Promise On Bank Deregulation?
STORY: After a bumpy week for stocks, Wall Street’s main indexes ended Friday with gains after cooler-than-expected inflation data eased worries about the path of interest rates.
You are viewing: Stocks rally after inflation data but close lower for the week
The Dow, S&P 500 and Nasdaq all added more than one percent.
See more : Global banks finance $420M to LCI and CMFL JV social projects
The personal consumption expenditures or PCE price index showed a 2.4% rise in the annual inflation rate for November, below economists’ estimates.
The report came after the Fed on Wednesday forecast just two interest rate cuts for 2025, sparking a sharp sell-off… with equities unable to bounce back on Thursday.
Alexander Morris is CEO and CIO of F/m Investments.
“Today stocks are getting a little bit of reprieve after a fairly difficult week, largely led by Jay Powell, reminding markets and incoming presidents alike that he and the Fed are in charge and they’re going to do what they think is best for the economy. [FLASH] I think the Fed is signaling very strongly to us that data dependency means really paying attention to inflation. We’d thought the shift had been made just to the jobs market. The Fed had been vocal about that. But now we hear Fed Governor Hammack making very clear that this could also be an inflation story for 2025. So data dependency really is the Fed paying attention to everything all at once.”
See more : Have You Set Financial Goals For 2025? Here’s Why It Matters More Than You Think
Stocks on the move Friday included Novo Nordisk, which shed nearly 18% after the company revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug CagriSema.
On the flipside, shares of Eli Lilly rose after the Food and Drug Administration approved its weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug green-lit to directly treat patients with the common sleeping disorder.
Despite Friday’s stock gains, the Nasdaq snapped a four-week winning streak, the S&P suffered its biggest weekly percentage decline in six weeks, and the Dow saw its third consecutive weekly fall.
Source link https://finance.yahoo.com/video/stocks-rally-inflation-data-close-235859391.html
Source: https://summacumlaude.site
Category: News